Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
The therapeutic benefits of cannabinoids remain unclear, especially when weighted against their adverse effects.
This review of clinical research reports the evidence regarding biomedical and behavioral treatments for psychostimulant withdrawal symptoms.
To understand what prescribing characteristics are associated with opioid overdose following buprenorphine taper.
The objectives of this study are to (1) identify changes introduced to OAT clinical guidelines in Ireland during the pandemic; and (2) develop consensus on whether the new recommendations should be
Discontinuation from benzodiazepines can be problematic for patients and may result in a withdrawal syndrome, which can be protracted and last months to years.
Some Rights Reserved National Safer Supply Community of Practice
